Objective To develop machine-learning (ML) models during the COVID-19 pandemic and adjacent time periods to evaluate the impact of data drift on model performance. Design This prognostic study used population-level administrative health data to develop ML prediction models.
Setting Alberta, Canada during 2019 - 2023. Participants All patients over 18 who received at least one opioid dispensation from a community pharmacy within the province of Alberta between 2019 - 2023.
Exposure Each opioid dispensation served as the unit-of-analysis. Main outcomes/measures Opioid-related outcomes were identified from linked health administrative datasets.
Light Gradient Boosting-machine models were developed on pre-pandemic, pandemic and endemic data and temporally validated on 2023 data (pre-pandemic model was also validated on 2020 - 2021 data) to predict the risk of emergency department visit, hospitalisation or mortality within 30-days of an opioid dispensation. We described key feature distributions across the study time period and changes in model prediction performance on the validation sets using relevant metrics.
BMJ Open published a clinical update in Research Highlights on 21 May 2026.
The item focuses on Impact of COVID-19-related data drift on machine-learning prognostic models predicting 30-day opioid-related emergency department visits, hospitalisation or mortality: a population-level administrative data study in Alberta, Canada.
Review the original article for the full source wording and details.